Welcome to the Cancer Diagnosis Program!
The Cancer Diagnosis Program strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative in vitro diagnostics, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.
For more information about the Cancer Diagnosis Program and its Branches, please click here.
News and Announcements
09/2021
Dr. Lyndsay Harris, Associate Director of the CDP, commemorates the 50th anniversary of the National Cancer Act with a Staff Highlight in the DCTD newsletter on the evolution of cancer biomarkers, diagnostics, and where research is headed.
04/2021
Click here to see recordings and abstracts from presentations by CDP and other DCTD programs at 2021 AACR.
11/2020
New funding opportunities available! PAR-20-313, PAR-20-314, and PAR-20-074 are now accepting applications.
08/2020
Check out our new funding opportunities from the SBIR! Click here!
10/2019
New publication on submitting diagnostic tissue blocks for NCI clinical trials. Check here for more publications.
08/2019
Check out new funding opportunities from the ITCR! For additional funding opportunities from the CDP, check here.
Sign up for Email Updates
Follow us on Twitter
Contact Us